- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04906226
Effect of Self-Foot Massage on Diabetic Individuals
May 26, 2021 updated by: KADRİYE SAYIN KASAR, Aksaray University
The Effect of Self-Foot Massage on Peripheral Neuropathic Pain, Peripheral Skin Temperature and Patient Comfort in Diabetic Individuals: A Randomized Controlled Trial
The aim of this study is to evaluate the effect of self-foot massage on peripheral neuropathic pain, peripheral skin temperature and patient comfort in individuals with diabetes.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Diabetes mellitus (DM) is the most important metabolic disease that can affect almost every organ system in the body.
Although diabetes causes many macrovascular and microvascular complications, one of the rare microvascular complications is peripheral neuropathy.
One of the common complementary and integrative applications in the management of diabetic peripheral neuropathy is foot massage.
The aim of this study is to evaluate the effect of self-foot massage on peripheral neuropathic pain, peripheral skin temperature and patient comfort in individuals with diabetes.
Individuals participating in the study will be divided into intervention and control groups.
The individuals in the foot massage group will be given foot massage training by the researcher.
Later, people with diabetes will be enabled to continue self-massage at home.
To encourage the continuation of the intervention, the researcher will be called once a week by phone and her questions will be answered.
There will be no additional application other than routine to the control group, data collection forms will be applied and recorded at the beginning of the study and at the end of four weeks.
In the collection of data, "Individual Description Form, Visuel Analog Scale- (VAS), DN4 Pain Questionnaire and General Comfort Questionnaire- Short form" will be used.
In addition, peripheral skin temperature will be measured with a skin thermometer.
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kadriye SAYIN KASAR, PhD,RN
- Phone Number: +90 0382 2882785
- Email: kadriye_syn_321@hotmail.com
Study Contact Backup
- Name: Aksaray University
Study Locations
-
-
-
Aksaray, Turkey, 68100
- Recruiting
- Aksaray University
-
Contact:
- Kadriye SAYIN KASAR, PhD, RN
- Phone Number: +90 05068662450
- Email: kadriye_syn_321@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years of age or above,
- Having been diagnosed with type 2 diabetes at least 6 months ago,
- HbA1c level> 6.5%,
- Being able to do personal care for personal hygiene management,
- No peripheral circulation problems,
- Do not have any problems such as speech or hearing that prevent communication,
- Physical and cognitive health levels are suitable for answering the data collection form,
- Agreeing to participate in the research,
- It is planned to include patients who can speak and understand Turkish.
Exclusion Criteria:
- Individuals with other health problems that may cause peripheral neuropathy (chemotherapy, neurological, etc.),
- Patients with organ damage (gangrene or foot / finger amputation) due to diabetes mellitus or any other reason, malignancy, tuberculosis, asthma, or any contagious disease,
- Individuals with a history of disease that may cause changes in peripheral skin temperature (Raynaud's disease, etc.)
- Who do not agree to participate in the research,
- Speaking and hearing impairments that interfere with the collection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Individuals participating in the study will be divided into intervention and control groups.
The individuals in the foot massage group will be given foot massage training by the researcher.
Later, people with diabetes will be enabled to continue self-massage at home.
To encourage the continuation of the intervention, the researcher will be called once a week by phone and her questions will be answered.
At the end of the four weeks, the patient will be interviewed again and data collection forms will be filled.
|
The individuals in the foot massage group will be given foot massage training by the researcher.
Later, people with diabetes will be enabled to continue self-massage at home.
To encourage the continuation of the intervention, the researcher will be called once a week by phone and her questions will be answered.
At the end of the four weeks, the patient will be interviewed again and data collection forms will be filled.
|
|
No Intervention: Control group
There will be no additional application other than routine to the control group, data collection forms will be applied and recorded at the beginning of the study and at the end of four weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visuel Analog Scale- (VAS)
Time Frame: 1 months
|
The Visual Analogue Scale (VAS), which is used for the assessment of pain, is used to convert some values that cannot be measured numerically into numerical ones.
|
1 months
|
|
DN4 Pain Questionnaire
Time Frame: 1 months
|
The DN4 pain questionnaire is a questionnaire that includes symptoms and signs associated with neuropathic pain.
|
1 months
|
|
General Comfort Questionnaire- Short form
Time Frame: 1 months
|
It is used to determine the comfort level of patients.
|
1 months
|
|
Peripheral skin temperature will be measured with a skin thermometer
Time Frame: 1 months
|
The skin temperature in the middle of the plantar surfaces of both feet is measured using the handheld digital skin thermometer.
|
1 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kadriye SAYIN KASAR, PhD, RN, Aksaray University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2021
Primary Completion (Anticipated)
December 30, 2021
Study Completion (Anticipated)
April 30, 2022
Study Registration Dates
First Submitted
May 24, 2021
First Submitted That Met QC Criteria
May 26, 2021
First Posted (Actual)
May 28, 2021
Study Record Updates
Last Update Posted (Actual)
May 28, 2021
Last Update Submitted That Met QC Criteria
May 26, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 2021-020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Medtronic MiniMed, Inc.RecruitingType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States, Australia, New Zealand
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on Self-foot massage
-
TC Erciyes UniversityCompletedAbdominal Pain | Satisfaction, Patient | DistentionTurkey
-
EMRE ERKALCompleted
-
Mersin UniversityCompletedHemodialysis PatientsTurkey
-
Harran UniversityCompleted
-
Saglik Bilimleri UniversitesiCompletedAnxiety | Bronchoscopy | Physiological ParametersTurkey
-
Istanbul Medeniyet UniversityIstanbul University - Cerrahpasa (IUC)RecruitingPain, Postoperative | Spinal FusionTurkey
-
Bandırma Onyedi Eylül UniversityCompletedPre-Eclampsia | Gestational Hypertension | Chronic Hypertension With Pre-Eclampsia | Superimposed Pre-EclampsiaTurkey
-
Karamanoğlu Mehmetbey UniversityActive, not recruitingInfantile Colic | Nurse's RoleTurkey
-
University of Houston DowntownNot yet recruiting
-
ayşenur kahveciNot yet recruitingCoronary Angiography (CAG)Turkey